[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_10784 

# __Use of drugs with potential side effects for covid-19 treatment__

## Articles mentionning the risk

* [Wu_current_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_509.md)

## Mitigations of this risk

* [Thorough clinical trials, monitoring for side effects, and continuous evaluation of drug effectiveness](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_12695.md)

## Name of the risk

Risk of adverse reactions and potential ineffectiveness

## People affected by this risk

* [Patients receiving the drugs for covid-19 treatment](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_8742.md)

## Stakeholders who can mitigate this risk

* [Healthcare professionals](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_32.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Clinical trial methodologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12700.md)
* [Drug monitoring technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_12702.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

